Steven Marotta
Stock Analyst at CL King
(1.36)
# 2,804
Out of 4,667 analysts
15
Total ratings
60%
Success rate
-8.53%
Average return
Main Sectors:
Stocks Rated by Steven Marotta
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GIII G-III Apparel Group | Downgrades: Neutral | n/a | $29.22 | - | 1 | Dec 1, 2022 | |
| SHOO Steven Madden | Upgrades: Buy | n/a | $42.82 | - | 1 | Sep 28, 2022 | |
| CTKB Cytek Biosciences | Initiates: Overweight | $28 | $6.46 | +333.44% | 1 | Aug 17, 2021 | |
| AVTR Avantor | Upgrades: Overweight | $32 → $41 | $20.36 | +101.38% | 3 | Aug 2, 2021 | |
| CAL Caleres | Upgrades: Buy | $29 | $30.46 | -4.79% | 2 | Jun 1, 2021 | |
| CROX Crocs | Downgrades: Neutral | n/a | $101.81 | - | 3 | Jul 17, 2020 | |
| GCO Genesco | Upgrades: Buy | n/a | $28.95 | - | 4 | Jan 21, 2020 |
G-III Apparel Group
Dec 1, 2022
Downgrades: Neutral
Price Target: n/a
Current: $29.22
Upside: -
Steven Madden
Sep 28, 2022
Upgrades: Buy
Price Target: n/a
Current: $42.82
Upside: -
Cytek Biosciences
Aug 17, 2021
Initiates: Overweight
Price Target: $28
Current: $6.46
Upside: +333.44%
Avantor
Aug 2, 2021
Upgrades: Overweight
Price Target: $32 → $41
Current: $20.36
Upside: +101.38%
Caleres
Jun 1, 2021
Upgrades: Buy
Price Target: $29
Current: $30.46
Upside: -4.79%
Crocs
Jul 17, 2020
Downgrades: Neutral
Price Target: n/a
Current: $101.81
Upside: -
Genesco
Jan 21, 2020
Upgrades: Buy
Price Target: n/a
Current: $28.95
Upside: -